The chemical class known as WDR36 activators encompasses a diverse group of compounds that can activate WDR36, a protein implicated in various cellular processes such as ribosome biogenesis, RNA processing, and possibly autophagy and intraocular pressure regulation. These activators can exert their influence through different mechanisms, depending on the pathway they impact. For example, certain activators can disrupt the normal synthesis and processing of RNA within the nucleus, leading to a cellular response that can activate WDR36 as a compensatory mechanism to maintain homeostasis in ribosomal assembly. Others can interfere with protein transport, exerting stress on the Golgi apparatus and activating WDR36 to stabilize cell function and ensure efficient protein sorting and delivery.
In addition to affecting RNA and protein pathways, some chemicals within this class can alter cellular signaling processes that can activate WDR36. The involvement of WDR36 in cellular signaling is less defined, yet it is evident that the protein can be activated in response to changes in signal transduction, such as those mediated by cAMP or cholesterol-derived molecules. This activation can be a result of the cell's effort to adjust to altered internal or external environments, maintaining equilibrium in processes such as autophagy, which is crucial for cellular turnover and health. These activators can also engage with stress response pathways, initiating a cascade of events that can activate WDR36 to help the cell cope with various stressors, including those that affect protein folding within the endoplasmic reticulum. Overall, the class of WDR36 activators represents a set of compounds that can influence a variety of biological processes, resulting in the upregulation of WDR36 activity to support cellular function and stability.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin suppresses ribosome biogenesis, which could activate WDR36 to enhance ribosome production in response to decreased mTOR signaling. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound intercalates into DNA, preventing RNA synthesis, which could activate WDR36 as the cell attempts to compensate for impaired rRNA processing and ribosomal assembly. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
An inhibitor of protein transport from the ER to the Golgi apparatus, Brefeldin A could activate WDR36 by impacting Golgi function and cellular homeostasis. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
Disrupting intracellular cholesterol transport, U18666A could activate WDR36 by influencing membrane dynamics and associated signaling pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By activating adenylate cyclase and elevating cAMP levels, Forskolin could activate WDR36 through cAMP-dependent signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 could activate WDR36 by modulating cellular stress responses that may implicate WDR36's role in the cell. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
An Hsp90 inhibitor, Geldanamycin could activate WDR36 by destabilizing proteins involved in growth signaling pathways, affecting ribosome biogenesis. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
By inhibiting N-linked glycosylation and causing ER stress, Tunicamycin could activate WDR36 as part of the unfolded protein response. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $77.00 $179.00 | 18 | |
A statin that inhibits HMG-CoA reductase, Mevastatin could activate WDR36 through changes in cell signaling due to reduced cholesterol synthesis. | ||||||